Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Additional investigations of GLP-1R expression in other metastatic sites, such as the liver and lung are warranted
Some combination products, such as Xultophy, contain both a long-acting insulin and a GLP-1 in the same pen
Well-established glycemic control across multiple indications and formulations
People who already have kidney disease need extra attention during this treatment
The most common side effects reported in trials include: Digestive issues Nausea (the most frequently reported side effect) Vomiting Diarrhoea Constipation Stomach pain or discomfort Loss of appetite Other reported effects Fatigue or tiredness Injection site reactions (redness, swelling, or irritation) Most side effects tend to be worse when starting the medication or increasing the dose, and often improve as your body adjusts
Lately, that topic is GLP-1s and drug pricing
